β2-Glycoprotein i reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome
✍ Scribed by Kenji Ichikawa; Munther A. Khamashta; Takao Koike; Eiji Matsuura; Graham R. V. Hughes
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 907 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
To elucidate the specificity of anticardiolipin antibodies (aCL) from patients with the antiphospholipid syndrome (APS) to various phospholipids (PLs), DNA, and &-glycoprotein I (&-GPI).
Methods. Five monoclonal aCL were established from peripheral blood lymphocytes of 3 patients with the APS. The reactivity of monoclonal aCL with various PLs, with DNA, and with &GPI was examined by enzyme-linked immunosorbent assay (ELISA).
Results. All of the monoclonal aCL bound to anionic PLs, only in the presence of p,-GPI. Neither monoclonal aCL nor &GPI bound to DNA. Monoclonal aCL bound to solid-phase &GPI on polystyrene ELISA plates that had carboxyl groups on their surface, but did not react with solid-phase &GPI on ordinary polystyrene plates. A mixture of &-GPI and CL inhibited the binding of monoclonal aCL to &-GPI, but CL or &GPI alone did not.
Conclusion.
Monoclonal aCL may recognize a cryptic epitope, which appears as a result of &GPI binding to anionic PLs or to polystyrene with carboxyl groups.
Antiphospholipid antibodies (aPL), including anticardiolipin antibodies (aCL), lupus anticoagulant (LA),
📜 SIMILAR VOLUMES
Patients with the antiphospholipid syndrome (APS) have autoantibodies directed against epitopes on β 2 glycoprotein I (β 2 GPI). We describe herein the performance characteristics of standardized enzyme-linked immunosorbent assays (ELISAs) for antiβ 2 GPI of the three major immunoglobulin classes: I